In dollar terms, revenue was up 21.6% to $6.1 billion, and net income was up 32% to $1.2 billion. “The quarter gone by was fairly balanced between health crisis and business opportunity. Our challenges in emerging markets, primarily led by India, results in overall reported growth (sequentially) of 2.5% in constant currency terms,” CEO and MD Rajesh Gopinathan said.
